These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24583336)

  • 41. Comparison of trigeminal and spinal modulation of pain and nociception.
    Rehberg B; Baars JH; Kotsch J; Koppe P; von Dincklage F
    Int J Neurosci; 2012 Jun; 122(6):298-304. PubMed ID: 22225522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Substance P release in the rat periaqueductal gray and preoptic anterior hypothalamus after noxious cold stimulation: effect of selective mu and kappa opioid agonists.
    Xin L; Geller EB; Liu-Chen LY; Chen C; Adler MW
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1055-63. PubMed ID: 9262375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic antidepressant treatment causes a selective reduction of mu-opioid receptor binding and functional coupling to G Proteins in the amygdala of fawn-hooded rats.
    Chen F; Lawrence AJ
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1020-6. PubMed ID: 15121763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treating pain with pain: supraspinal mechanisms of endogenous analgesia elicited by heterotopic noxious conditioning stimulation.
    Sprenger C; Bingel U; Büchel C
    Pain; 2011 Feb; 152(2):428-439. PubMed ID: 21196078
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterotopic CO2 laser stimulation inhibits tooth-related somatosensory evoked potentials.
    Fujii-Abe K; Oono Y; Motohashi K; Fukayama H; Umino M
    Pain Med; 2010 Jun; 11(6):825-33. PubMed ID: 20456077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psychophysical and electrophysiological approaches to the pain-relieving effects of heterotopic nociceptive stimuli.
    Willer JC; Roby A; Le Bars D
    Brain; 1984 Dec; 107 ( Pt 4)():1095-112. PubMed ID: 6509310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffuse noxious inhibitory control. Reappraisal by pain-related somatosensory evoked potentials following CO2 laser stimulation.
    Kakigi R
    J Neurol Sci; 1994 Sep; 125(2):198-205. PubMed ID: 7807168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heterotopic painful stimulation decreases the late component of somatosensory evoked potentials induced by electrical tooth stimulation.
    Motohashi K; Umino M
    Brain Res Cogn Brain Res; 2001 Mar; 11(1):39-46. PubMed ID: 11240110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Somatosensory perception and function of diffuse noxious inhibitory controls (DNIC) in patients suffering from rheumatoid arthritis.
    Leffler AS; Kosek E; Lerndal T; Nordmark B; Hansson P
    Eur J Pain; 2002; 6(2):161-76. PubMed ID: 11900476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Learned control over spinal nociception reduces supraspinal nociception as quantified by late somatosensory evoked potentials.
    Ruscheweyh R; Bäumler M; Feller M; Krafft S; Sommer J; Straube A
    Pain; 2015 Dec; 156(12):2505-2513. PubMed ID: 26270584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurophysiological assessment of spinal cord stimulation in failed back surgery syndrome.
    de Andrade DC; Bendib B; Hattou M; Keravel Y; Nguyen JP; Lefaucheur JP
    Pain; 2010 Sep; 150(3):485-491. PubMed ID: 20591571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regional mu opioid receptor regulation of sensory and affective dimensions of pain.
    Zubieta JK; Smith YR; Bueller JA; Xu Y; Kilbourn MR; Jewett DM; Meyer CR; Koeppe RA; Stohler CS
    Science; 2001 Jul; 293(5528):311-5. PubMed ID: 11452128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of opioid receptors in the CGRP8-37-induced inhibition of the activity of wide-dynamic-range neurons in the spinal dorsal horn of rats.
    Yan Y; Yu LC
    J Neurosci Res; 2004 Jul; 77(1):148-52. PubMed ID: 15197748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Basal opioid receptor binding is associated with differences in sensory perception in healthy human subjects: a [18F]diprenorphine PET study.
    Mueller C; Klega A; Buchholz HG; Rolke R; Magerl W; Schirrmacher R; Schirrmacher E; Birklein F; Treede RD; Schreckenberger M
    Neuroimage; 2010 Jan; 49(1):731-7. PubMed ID: 19703571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Toluene and TCE decrease binding to mu-opioid receptors, but not to benzodiazepine and NMDA receptors in mouse brain.
    Páez-Martínez N; Ambrosio E; García-Lecumberri C; Rocha L; Montoya GL; Cruz SL
    Ann N Y Acad Sci; 2008 Oct; 1139():390-401. PubMed ID: 18991886
    [TBL] [Abstract][Full Text] [Related]  

  • 56. individual variation in sleep quality and duration is related to cerebral mu opioid receptor binding potential during tonic laboratory pain in healthy subjects.
    Campbell CM; Bounds SC; Kuwabara H; Edwards RR; Campbell JN; Haythornthwaite JA; Smith MT
    Pain Med; 2013 Dec; 14(12):1882-92. PubMed ID: 24102962
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET).
    Bencherif B; Fuchs PN; Sheth R; Dannals RF; Campbell JN; Frost JJ
    Pain; 2002 Oct; 99(3):589-598. PubMed ID: 12406535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diffuse noxious inhibitory controls in man. Involvement of the spinoreticular tract.
    De Broucker T; Cesaro P; Willer JC; Le Bars D
    Brain; 1990 Aug; 113 ( Pt 4)():1223-34. PubMed ID: 2397390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission.
    Zubieta JK; Ketter TA; Bueller JA; Xu Y; Kilbourn MR; Young EA; Koeppe RA
    Arch Gen Psychiatry; 2003 Nov; 60(11):1145-53. PubMed ID: 14609890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conditioned Pain Modulation: Comparison of the Effects on Nociceptive and Non-nociceptive Blink Reflex.
    Kinukawa TA; Inui K; Taniguchi T; Takeuchi N; Sugiyama S; Nishihara M; Nishiwaki K; Kakigi R
    Neuroscience; 2021 Aug; 468():168-175. PubMed ID: 34147564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.